PATIENTS, RESIDENTS & CLIENTS
VISITORS
FIND HEALTH CARE
HEALTH INFORMATION
EMPLOYEES AND PHYSICIANS
Cancer Care
Cancer Care
About Us
Accountability
Regional cancer centres
New cancer care centre
Cancer care team
Leadership team
Patient and family advisory council
About Us
Accountability
Regional cancer centres
New cancer care centre
Cancer care team
Leadership team
Patient and family advisory council
Patients & Families
Cancer patients about COVID-19
What you need to know
For your visit
Cancer patient navigation
Safe health practices
Patient education resources
Privacy and confidentiality
Noona app
Community resources
Patients & Families
Cancer patients about COVID-19
What you need to know
For your visit
Cancer patient navigation
Safe health practices
Patient education resources
Privacy and confidentiality
Noona app
Community resources
Cancer Care Services
Chemotherapy
Clinical trials
Consultative services
NL Cancer Care Registry (NLCCR)
Nursing
Nutrition services
Pharmacy
Radiation therapy
Social work
Surgery
Telehealth/Tele-oncology
Cancer Care Services
Chemotherapy
Clinical trials
Consultative services
NL Cancer Care Registry (NLCCR)
Nursing
Nutrition services
Pharmacy
Radiation therapy
Social work
Surgery
Telehealth/Tele-oncology
Prevention & Screening
Breast Screening Program
Cervical Screening Program
Colon Cancer Screening Program
Smoking Cessation Program
Prevention & Screening
Breast Screening Program
Cervical Screening Program
Colon Cancer Screening Program
Smoking Cessation Program
For health professionals
Guidelines
Reports
Pre-printed orders
Forms & resources
Provincial palliative care resource guide
For health professionals
Refer a patient
Guidelines
Pre-printed orders
Reports
Forms & resources
Provincial palliative care resource guide
Home
>
FOLFIRI bevacizumab Regimen (CP-0027) June 2018
Font Size
Print
FOLFIRI bevacizumab Regimen (CP-0027) June 2018
FOLFIRI bevacizumab Regimen (CP-0027) June 2018
FOLFIRI bevacizumab Regimen (CP-0027) June 2018
Share This Page:
Last updated: 2020-10-07
